Home › NDC Lookup › RxCUI directory › RxCUI 2609605

Testosterone undecanoate 150 MG Oral Capsule — RxCUI 2609605

RxNorm drug concept · Semantic clinical drug
RxCUI 2609605 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2609605
Official nameTestosterone undecanoate 150 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Testosterone Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Washing your hands is important, but it's not enough on its own. The gel on your shoulders and arms stays active on your skin for hours. If a child or woman touches that area, test...
  • Why do I need to cover up after putting on the gel — can't I just wash my hands?
  • Your prescriber will check your testosterone level with a morning blood draw — typically around 2 weeks and 4 weeks after starting or changing your dose. The goal is to keep your l...
  • How will I know if the dose is right for me?
📖 Read our full Testosterone Transdermal Patch guide →

🕸️ Concept Web — How Testosterone undecanoate 150 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Testosterone undecanoate 150 MG Oral Capsule RxCUI 2609605

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Testosterone 10379
    • Testosterone undecanoate 37864
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Kyzatrex 2609598
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Testosterone Oral Capsule 374051
    • Testosterone undecanoate Oral Capsule 2649157
    • Testosterone Oral Product 1164842
    • Testosterone Pill 1164843
    • Testosterone undecanoate Oral Product 2659803
    • Testosterone undecanoate Pill 2660921
    • Testosterone Oral Capsule [Kyzatrex] 2609602
    • Testosterone undecanoate Oral Capsule [Kyzatrex] 2654367
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Testosterone undecanoate 150 MG SCDC · 2609604
  • Testosterone Oral Capsule SCDF · 374051
  • Testosterone undecanoate Oral Capsule SCDFP · 2649157
  • Testosterone Oral Product SCDG · 1164842
  • Testosterone Pill SCDG · 1164843
  • Testosterone undecanoate Oral Product SCDGP · 2659803
  • Testosterone undecanoate Pill SCDGP · 2660921

Brand-Name Concepts

  • Testosterone undecanoate 150 MG Oral Capsule [Kyzatrex] SBD · 2609607
  • Testosterone undecanoate 150 MG [Kyzatrex] SBDC · 2609606
  • Testosterone Oral Capsule [Kyzatrex] SBDF · 2609602
  • Testosterone undecanoate Oral Capsule [Kyzatrex] SBDFP · 2654367
  • Kyzatrex Oral Product SBDG · 2609600
  • Kyzatrex Pill SBDG · 2609601
  • Kyzatrex BN · 2609598

📦 FDA Products & Package NDCs

2 products · 5 package NDCs
5 package NDCs map to RxCUI 2609605 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
80603-0103-11 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-103-11) Kyzatrex Marius Pharmaceuticals 2022-07-27
80603-0103-22 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-103-22) Kyzatrex Marius Pharmaceuticals 2022-07-27
80603-0105-11 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-105-11) Kyzatrex Marius Pharmaceuticals 2022-07-27
80603-0105-22 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-105-22) Kyzatrex Marius Pharmaceuticals 2022-07-27
80603-0105-33 60 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-105-33) Kyzatrex Marius Pharmaceuticals 2023-09-25
Observed labelers: Marius Pharmaceuticals (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.